Similarly, genetically engineered TRAIL-expressing adipose-derived mesenchymal stem cells (A-MSCs-TRAIL+) created by lentiviral transductions have also shown potent anti-tumour effects in various cancer types, such as glioblastoma, hepatocellular carcinoma and haematological malignancies, such as acute lymphocytic leukaemia, or chronic myelogenous leukaemia [179,180,181,182]. The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.